Stay updated on Panitumumab, Nivolumab, Ipilimumab in mCRC Clinical Trial
Sign up to get notified when there's something new on the Panitumumab, Nivolumab, Ipilimumab in mCRC Clinical Trial page.

Latest updates to the Panitumumab, Nivolumab, Ipilimumab in mCRC Clinical Trial page
- Check2 days agoNo Change Detected
- Check9 days agoNo Change Detected
- Check16 days agoChange DetectedA consolidated Locations section now lists Florida, Indiana, North Carolina, Tennessee, and Washington. The HHS Vulnerability Disclosure link was removed, and the page revision updated to v3.3.3.SummaryDifference0.6%

- Check23 days agoNo Change Detected
- Check37 days agoChange DetectedRevision tag updated from v3.2.0 to v3.3.2. This change does not affect study content or user interactions.SummaryDifference0.1%

- Check45 days agoChange DetectedRemoved the government funding status notice from the bottom of the ClinicalTrials.gov page. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.4%

- Check67 days agoChange DetectedThe page shows the same study details (title, status, interventions, eligibility criteria, endpoints) with only minor formatting changes. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.4%

- Check88 days agoChange DetectedSignificant update: new operating-status notice and version bump to v3.2.0; previous v3.1.0 tag removed. Core content impacted by the new status information.SummaryDifference3%

- Check95 days agoChange Detected- Updated version from v3.0.2 to v3.1.0. - No other content changes detected.SummaryDifference0.1%

Stay in the know with updates to Panitumumab, Nivolumab, Ipilimumab in mCRC Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Panitumumab, Nivolumab, Ipilimumab in mCRC Clinical Trial page.